| [1] |
FU Yi, YANG Xuesong, JIN Ligang, ZHAI Hongli, JIN Xiaoling.
Correlation between small and dense low-density lipoprotein cholesterol and acute coronary syndrome with the occurrence of long-term adverse cardiovascular events
[J]. Laboratory Medicine, 2023, 38(9): 878-883.
|
| [2] |
ZHANG Xin, MA Lijuan.
Role of cardiac markers in children
[J]. Laboratory Medicine, 2023, 38(6): 505-509.
|
| [3] |
YIN Ya, PAN Yuan, ZHOU Hongwei, SHEN Wei.
Application progress of BNP and NT-proBNP in neonates
[J]. Laboratory Medicine, 2023, 38(6): 518-523.
|
| [4] |
LI Li, SUN Haiyan, LI Yuanrui, DOU Min, TANG Wen, JIANG Limin, SHEN Lisong.
Changes and clinical roles of perioperative NT-proBNP and PCT in children with congenital heart disease
[J]. Laboratory Medicine, 2023, 38(6): 524-531.
|
| [5] |
LIU Yanan, XIA Min, HU Shaohua, ZHENG Yue, ZHANG Hong.
Roles of lymphocyte subsets，inflammatory factors and NT-proBNP in diagnosis of Kawasaki disease
[J]. Laboratory Medicine, 2023, 38(6): 532-537.
|
| [6] |
ZHENG Zhiyou, LI Xingzhao, XIE Yage.
Changes and clinical significance of HbA1c，NT-proBNP，Hcy，SOD and TC levels in patients with diabetes cardiomyopathy
[J]. Laboratory Medicine, 2023, 38(3): 282-286.
|
| [7] |
MA Jianguo, ZHU Xiaolin, DING Yongguang, YIN Meng, LI Hongchun.
Predictive values of red blood cell distribution width and myocardial markers for acute myocardial infarction in patients with CAS
[J]. Laboratory Medicine, 2022, 37(12): 1164-1168.
|
| [8] |
HE Chengshan, YAO Xiaoyang, JIANG Xiudi, LU Zhicheng.
Microarray chemiluminescence immunoassay for quantitative detection of cardiac troponin I autoantibodies and preliminary clinical applications
[J]. Laboratory Medicine, 2021, 36(3): 318-324.
|
| [9] |
ZHU Chuanxin, ZHOU Yuping, HE Yan, ZHOU Qin.
Diagnostic role of NLR,CRP,PCT,DD and NT-proBNP in severe corona virus disease 2019
[J]. Laboratory Medicine, 2021, 36(2): 190-193.
|
| [10] |
DU Kun, YAN Jianhua, CHEN Ming, YANG Junyao, ZHANG Guanghui.
Role of risk stratification and prognosis of sST2 in acute coronary syndrome patients after percutaneous coronary intervention
[J]. Laboratory Medicine, 2021, 36(10): 1020-1025.
|
| [11] |
CHEN Bin, LU Weiwei, XU Zhongyu.
Roles of serum NT-proBNP,CRP and MMP-9 in children with Kawasaki disease
[J]. Laboratory Medicine, 2020, 35(3): 243-246.
|
| [12] |
ZHENG Wei, HAO Aijun, ZHU Guoyong, ZHANG Yinhui, WANG Dongyun, PANg Jie.
Clinical roles of SAA,CRP,LYMPH#,NT-proBNP and DD in COVID-19
[J]. Laboratory Medicine, 2020, 35(12): 1238-1242.
|
| [13] |
SHU Ming, JIN Lu, CHEN Qiuying.
Role of serum hepcidin in the diagnosis of myocardial damage among coronary heart disease patients
[J]. Laboratory Medicine, 2019, 34(9): 783-786.
|
| [14] |
DING Hui, LI Zhumeng, WANG Yin, WANG Dong, SHENG Huiming.
Analysis of serum lipoprotein （a） and homocysteine levels in patients with acute coronary syndrome
[J]. Laboratory Medicine, 2019, 34(12): 1082-1087.
|
| [15] |
LU Qiuya, LU Yide, SUN Aihua, MA Weiyun, ZHOU Yiqiong, WANG Xuefeng.
Thromboelastography-MA parameter in the diagnosis of acute coronary syndrome
[J]. Laboratory Medicine, 2018, 33(2): 119-123.
|
